Nuances in Efficacy, MACE Risk Revealed Between JAKi, TNFi
Three studies provide more data on risk for major adverse cardiovascular events with JAK inhibitors vs TNF inhibitors, as well as their efficacy in patients with different levels of risk.
Anja Strangfeld Eli Lilly Maya Buch Romain Aymon Manchester Biomedical Research Centre University Of Manchester
Source: medscape.com